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Abstract Damaged mitochondria are selectively eliminated by mitophagy. Parkin and PINK1,
gene products mutated in familial Parkinson’s disease, play essential roles in mitophagy through
ubiquitination of mitochondria. Cargo ubiquitination by E3 ubiquitin ligase Parkin is important to
trigger selective autophagy. Although autophagy receptors recruit LC3-labeled autophagic
membranes onto damaged mitochondria, how other essential autophagy units such as ATG9A-
integrated vesicles are recruited remains unclear. Here, using mammalian cultured cells, we
demonstrate that RABGEF1, the upstream factor of the endosomal Rab GTPase cascade, is
recruited to damaged mitochondria via ubiquitin binding downstream of Parkin. RABGEF1 directs
the downstream Rab proteins, RAB5 and RAB7A, to damaged mitochondria, whose associations
are further regulated by mitochondrial Rab-GAPs. Furthermore, depletion of RAB7A inhibited
ATG9A vesicle assembly and subsequent encapsulation of the mitochondria by autophagic
membranes. These results strongly suggest that endosomal Rab cycles on damaged mitochondria
are a crucial regulator of mitophagy through assembling ATG9A vesicles.
DOI: https://doi.org/10.7554/eLife.31326.001
Introduction
To maintain cell homeostasis, damaged mitochondria have to be eliminated from cells, especially
post-mitotic cells such as neurons. Parkin and PINK1, two gene products mutated in familial Parkin-
son’s disease, function in a mitochondrial quality control pathway via autophagy, called mitophagy
(Pickrell and Youle, 2015; Yamano et al., 2016). PINK1 is an ubiquitin kinase (Kane et al., 2014;
Kazlauskaite et al., 2014; Koyano et al., 2014) that is rapidly degraded through the N-end rule
pathway after translocation into healthy mitochondria (Yamano and Youle, 2013) but accumulates
on damaged mitochondria upon loss of membrane potential (Geisler et al., 2010; Matsuda et al.,
2010; Narendra et al., 2010; Vives-Bauza et al., 2010). Recent studies have revealed that phos-
phorylated ubiquitin made by PINK1 on damaged mitochondria functions as a receptor for E3
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ubiquitin ligase Parkin (Okatsu et al., 2015; Ordureau et al., 2015; Ordureau et al., 2014) as well
as an activator of the ligase activity. Once Parkin is recruited to damaged mitochondria, it becomes
fully active through further phosphorylation (Kondapalli et al., 2012; Shiba-Fukushima et al., 2012).
As a result, through positive feedback ubiquitination cycles (Okatsu et al., 2015; Ordureau et al.,
2014), many outer mitochondrial membrane (OMM) proteins including MFN1, MFN2 and TOMM20
are ubiquitinated by Parkin (Bingol et al., 2014; Rose et al., 2016; Sarraf et al., 2013), and some of
these ubiquitinated substrates either undergo proteasomal degradation (Tanaka et al., 2010;
Yoshii et al., 2011) or behave as signals that trigger autophagy-dependent lysosomal degradation
(Narendra et al., 2008).
Macroautophagy (hereafter referred to as autophagy) is a eukaryotic conserved mechanism for
mediating degradation of cellular components. Many autophagy proteins have been identified in
mammals, and form several functional units (Feng et al., 2014; Mizushima et al., 2011). The most
upstream regulator is the ULK1 complex, which consists of ULK1, ATG13, RB1CC1/FIP200, and
ATG101. Another regulator, the phosphatidylinositol 3-kinase (PI3K) complex generates phosphati-
dylinositol 3-phosphate (PI3P). ATG9A is the only known multispannning membrane protein among
the essential autophagy proteins. Under basal conditions, ATG9A localizes on the trans-Golgi net-
work (TGN) and recycling endosomes as well as in the cytosol as small membrane vesicles
(Reggiori and Tooze, 2012; Yamamoto et al., 2012). Upon autophagy stimulation, ATG9A is tran-
siently recruited to the sites of the autophagosome biogenesis, although its precise role remains
unclear. Two ubiquitin-like conjugation machineries, ATG5-ATG12 and phosphatidylethanolamine
(PE)-LC3 are also important for making enclosed autophagosomes (Tsuboyama et al., 2016). PE-
LC3 (also known as lipidated LC3) stably associates with autophagic membranes, which can be used
as an autophagy marker (Kabeya et al., 2000). Furthermore, factors of cellular membrane trafficking
systems including small GTPases such as Rab proteins and their regulators, and SNARE proteins
have recently shown to support autophagy biogenesis.
Accumulating evidence has shown that autophagy coordinates the ubiquitin/proteasome system,
especially in a selective autophagy including mitophagy. The well-characterized proteins that con-
nect autophagy and ubiquitin are autophagy receptors such as OPTN, CALCOCO2/NDP52, and
SQSTM1/p62, all of which contain both ubiquitin-binding domains (UBDs) and LC3-interacting motifs
(Wild et al., 2014). Therefore, these proteins can deliver LC3-labeled phagophore to ubiquitin-deco-
rated mitochondria. However, other essential autophagy units also have to be recruited onto the sur-
face of the damaged mitochondria, probably independent of LC3 (Itakura et al., 2012), to elongate
phagophore and/or construct enclosed autophagosomes, while our understanding is limited.
We previously showed that the mitochondrial protein FIS1 and its interacting mitochondrial Rab
GTPase-activating proteins (GAPs), TBC1D15 and TBC1D17, are important for autophagosomal bio-
genesis during mitophagy (Yamano et al., 2014). The loss of FIS1 inhibits elimination of damaged
mitochondria in cultured cells (Yamano et al., 2014), inhibits elimination of paternal mitochondria in
mouse embryos (Rojansky et al., 2016) and accumulates LC3 in C. elegans (Shen et al., 2014). The
obvious phenomenon during Parkin-mediated mitophagy following loss of FIS1 or TBC1D15 in cul-
tured cells is the accumulation of LC3B that is suppressed by RAB7A siRNA. Therefore, accumulation
of excess amounts of LC3B during mitophagy is RAB7-dependent, but the molecular mechanism
remains unclear.
In this study, we show that RABGEF1, a guanine nucleotide exchange factor (GEF) of endosomal
Rab proteins, which contains UBDs, is recruited to damaged mitochondria in a Parkin-dependent
manner. RABGEF1 directs the downstream Rab proteins, RAB5 and RAB7A, to damaged mitochon-
dria, that is further regulated by mitochondrial Rab-GAPs. Depletion of RAB7A inhibits ATG9A vesi-
cle assembly and subsequent encapsulation of the mitochondria by autophagic membranes. From
these results, we propose that endosomal Rab cycling at damaged mitochondria is a crucial regula-
tor of mitophagy through recruitment of ATG9A vesicles.
Results
RAB7A is recruited to damaged mitochondria during mitophagy
We first explored the localization of RAB7A during mitophagy. Without stimulation of mitophagy,
Parkin localizes throughout the cytosol and YFP-RAB7A mainly colocalizes with a late endosome/
Yamano et al. eLife 2018;7:e31326. DOI: https://doi.org/10.7554/eLife.31326 2 of 32
Research article Cell Biology
lysosome marker LAMP2 in WT, FIS1-/- and TBC1D15/17 double knockout (DKO) cells (Figure 1—
figure supplement 1A), but not with a mitochondrial marker TOMM20 (Figure 1—figure supple-
ment 1B), confirming that RAB7A is on the late endosomes and lysosomes under basal conditions.
Three hours of valinomycin treatment, which disrupts the membrane potential, resulted in Parkin
translocation to mitochondria (Figure 1A). Although a minute amount of YFP-RAB7A colocalizes
with damaged mitochondria in WT cells, loss of mitochondrial Rab-GAPs, TBC1D15 and TBC1D17,
or loss of their receptor FIS1 greatly induced colocalization of YFP-RAB7A with the mitochondria
(Figure 1A). Although substantial amounts of RAB7A still localize on the lysosomes even in FIS1-/-
and TBC1D15/17 DKO cells during mitophagy (Figure 1B), RAB7A recruitment to mitochondria
does not reflect lysosome localization with mitochondria (Figure 1C). Next, we observed localization
of endogenous RAB7A during mitophagy. We first confirmed that immunostained signals of anti-
RAB7 antibody we used were overlapped with LAMP2 signals (Figure 1—figure supplement 2A)
and that RAB7A siRNA treatment drastically reduced the signal (Figure 1—figure supplement 2B),
indicating that the antibody specifically recognizes endogenous RAB7A. When mitophagy was
induced by 3 hr of valinomycin treatment, a portion of endogenous RAB7A was colocalized with
damaged mitochondria in FIS1-/- and TBC1D15/17 DKO cells (Figure 1—figure supplement 2C).
These results demonstrate that both endogenous and exogenous RAB7A, but not the lysosome, is
recruited to mitochondria during mitophagy and RAB7A accumulation is enhanced by loss of mito-
chondrial Rab-GAPs, consistent with the idea that Rab-GAPs facilitate the dissociation of Rab pro-
teins from target membranes. We next asked how RAB7A localizes to mitochondria. Without Parkin
overexpression, RAB7A was not recruited to mitochondria, indicating that mitophagy stimulation by
Parkin is required (Figure 1D). In general, membrane tethering of Rab proteins requires their
GTPase activities and C-terminal posttranslational prenylation (Mu¨ller and Goody, 2017). Therefore,
we tested the RAB7A T22N mutant that locks the protein in a GDP-bound conformation, thereby
reducing the GTPase activity and a C-terminal 4aa deletion (DC) mutant in which prenylation is
impaired. Although localization patterns of RAB7A Q67L (a GTP-locked) and T22N mutants under
growing conditions looked similar to that of RAB7A WT, following mitophagy induction, the T22N
mutant was minimally recruited to mitochondria (Figure 1E and G) in contrast to the Q67L mutant
(Figure 1E). Furthermore, the DC mutant did not translocate to mitochondria when Parkin was
recruited to damaged mitochondria (Figure 1F and G). These data indicate that the GTPase activity
and the C-terminal prenylation are essential for RAB7A to be recruited to damaged mitochondria.
To clarify whether RAB7A associates to the OMM directly or via autophagic membranes, we first
tested colocalization of RAB7A and LC3B-labeled autophagic membranes. Under basal conditions,
only a small number of YFP-LC3B dots was detected (Figure 2A), but after valinomycin treatment,
WT cells formed many dot-like structures near mitochondria, indicating autophagic membranes
(Figure 2B, panel a and b). Interestingly, RAB7A was found to be associated with WT mitochondria
weakly, and sometimes enriched portions of the RAB7A signal on the mitochondria overlapped YFP-
LC3B signal, suggesting that RAB7A may interact with both autophagic membranes and damaged
mitochondria. On the other hand, loss of FIS1 or loss of TBC1D15/17 caused excessive YFP-LC3B
accumulation as reported previously (Yamano et al., 2014). 2HA-RAB7A strongly associates with
damaged mitochondria in areas lacking YFP-LC3B-labeled membranes in FIS1-/- and TBC1D15/17
DKO cells (Figure 2B, panel c-f), suggesting direct association of RAB7A to the mitochondria. To
rule out the possibility that other membrane structures intervene between RAB7A and the OMM for
the association, we conducted immunoelectron microscopy (Figure 2C). While gold particles
attached to YFP-RAB7A mainly localize on late endosomes/lysosomes in TBC1D15/17 DKO cells
under basal conditions (Figure 2C,a and b), they directly associate to the surface of the OMM after
mitophagy stimulation with no other membrane found between RAB7A and the OMM (Figure 2C,c–
f). Therefore, it appears that RAB7A can directly attach to the OMM.
RAB7A is required for an early step of autophagosome biogenesis
It has been reported that RAB7A is involved in the fusion between autophagosomes and lysosomes
at the downstream stage of autophagy (Gutierrez et al., 2004; Ja¨ger et al., 2004). However, since
(1) RAB7A is recruited to mitochondria during mitophagy and (2) mitochondrial RAB7A-GAPs control
precise encapsulation of mitochondria by autophagic membranes during mitophagy (Yamano et al.,
2014), we hypothesized that RAB7A acts more upstream in autophagosome biogenesis during
mitophagy. To examine autophagic structures in RAB7A-depleted cells, we knocked down RAB7A
Yamano et al. eLife 2018;7:e31326. DOI: https://doi.org/10.7554/eLife.31326 3 of 32
Research article Cell Biology
Figure 1. RAB7A is recruited to damaged mitochondria during mitophagy. The indicated HCT116 cells stably expressing mCherry-Parkin and YFP-
RAB7A (A and B), mCherry-Parkin alone (C), 2HA-RAB7A alone (D), or mCherry-Parkin and indicated RAB7A mutant (E and F) were treated with DMSO
or valinomycin for 3 hr followed by immunostaining. Magnified images are also shown for A-C, and E. Bars, 10 mm. (G) Quantification of RAB7A
recruitment to damaged mitochondria. Overlapped RAB7A signals with TOMM20 per total RAB7A signals were measured. Total RAB7A signal in each
Figure 1 continued on next page
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(Figure 3A) and observed distributions of various autophagy-related proteins required for phago-
phore and/or autophagosome formation at different stages; ULK1 and ATG13 for early nucleation,
DFCP1 (also known as ZFYVE1) as an omegasome marker, and WIPI1 that binds to PI3P, and
ATG16L1 required for lipidation of LC3. They all formed dot-like or ring-like structures near dam-
aged mitochondria after 3 hr of mitophagy stimulation (Figure 3—figure supplement 1), but the
numbers or morphologies of them did not detectably change between control and RAB7A siRNA-
treated cells (Figure 3—figure supplement 1). When YFP-LC3B was observed during mitophagy,
many spherical structures surrounding the mitochondrial matrix protein PDHA1 were found in con-
trol siRNA-treated cells (Figure 3B). However, while YFP-LC3B was still recruited to damaged mito-
chondria as dot-like structures during mitophagy in RAB7A siRNA-treated cells, the number of
spherical structures containing PDHA1 was significantly reduced (Figure 3B and C). These results
suggest that the phagophores in RAB7A-depleted cells cannot efficiently engulf damaged mitochon-
dria. Interestingly, we found that the recruitment of ATG9A was also impaired by depletion of
RAB7A. ATG9A is present in the cytosol as well as on the TGN in small vesicles (Figure 3D, and
[Puri et al., 2013; Young et al., 2006]). After 3 hr of mitophagy stimulation, endogenous ATG9A
assembled into larger dots on mitochondria in control siRNA-treated cells (Figure 3D), but much
less so after knocking down of RAB7A (Figure 3D and E). We also noticed that ATG9A on the Golgi
apparatus was reduced upon mitophagy in control siRNA cells, but not in RAB7A siRNA-treated cells
(Figure 3D and F). Furthermore, most of the ATG9A dots colocalized with LC3-labeled autophagic
membranes upon mitophagy stimulation (Figure 4A). To analyze this in more detail, we used
TBC1D15/17 DKO cells because loss of the mitochondrial RAB7-GAPs excessively activates RAB7A
and enhances LC3B accumulation near damaged mitochondria. As shown in Figure 4B and C and
Figure 4—figure supplement 1A, higher levels of ATG9A vesicles were localized close to the LC3-
labeled structures in TBC1D15/17 DKO cells. In sharp contrast, the number of ATG16L1 dots in
TBC1D15/17 DKO cells was quite similar to that in WT cells (Figure 4—figure supplement 1B), sug-
gesting the specificity of ATG9A for expanding the phagophore.
RAB7A is required for elimination of damaged mitochondria
To assess whether RAB7A is required for mitophagy, we performed mitochondria clearance assays.
HeLa cells stably expressing YFP-Parkin were treated with control or RAB7A siRNA followed by vali-
nomycin exposure for various times (Figure 5A). MFN2 was completely degraded within 3 hr
(Figure 5A), consistent with the previous reports (Tanaka et al., 2010; Yoshii et al., 2011) showing
that MFN2 is rapidly degraded by ubiquitin-proteasome pathway prior to autophagic degradation.
In control siRNA cells, TOMM20 and MT-CO2 (a mitochondrial DNA (mtDNA)-encoded matrix pro-
tein) were efficiently degraded after 36 hr of valinomycin treatment (Figure 5A). However, in RAB7A
siRNA-treated cells, protein levels of TOMM20 and especially MT-CO2 were not altered even after
36 hr (Figure 5A). A defect in degradation of lipidated LC3B was also observed in RAB7A-depleted
cells (Figure 5A), suggesting that autophagic flux is inhibited by a reduced level of RAB7A. Similar
mitophagy defects were also observed by microscopic analysis (Figure 5B). Parkin translocation in
RAB7A siRNA-treated cells was found to be similar to those in control siRNA-treated cells
(Figure 5C). 24 hr of valinomycin treatment resulted in efficient degradation of TOMM20, PDHA1,
and mtDNA in control siRNA-treated cells, whereas RAB7A siRNA treatment blocked their
Figure 1 continued
cell set to 100%. Error bars represent mean ± SE of at least two independent experiments. Statistical differences were determined by one-way ANOVA
with Dunnett’s multiple comparisons test. ***p<0.001.
DOI: https://doi.org/10.7554/eLife.31326.002
The following source data and figure supplements are available for figure 1:
Source data 1. This excel file contains quantification of recruitment of RAB7 WT and mutants to damaged mitochondria.
DOI: https://doi.org/10.7554/eLife.31326.005
Figure supplement 1. RAB7A localization under basal conditions.
DOI: https://doi.org/10.7554/eLife.31326.003
Figure supplement 2. Mitochondrial recruitment of endogenous RAB7A during mitophagy.
DOI: https://doi.org/10.7554/eLife.31326.004
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degradation (Figure 5B and D–F). These results indicate that RAB7A is important for efficient mito-
chondrial clearance.
MON1/CCZ1 complex directs RAB7A to damaged mitochondria
RAB7A normally associates with the late endosome/lysosome membranes. To clarify how RAB7A is
recruited to damaged mitochondria, we identified RAB7A-interacting proteins during mitophagy by
mass spectrometry. We used the RAB7A GDP-locked T22N mutant as (1) Rab-GEFs are
Figure 2. RAB7A directly associates to the outer membrane of damaged mitochondria. (A and B) The indicated HCT116 cells stably expressing YFP-
LC3B, mCherry-Parkin and 2HA-RAB7A were treated with DMSO (A) or valinomycin (B) for 3 hr, and subjected to immunostaining. The magnified
images of the cells treated with valinomycin were shown in a-f. Bars, 10 mm. (C) TBC1D15/17 DKO cells stably expressing mCherry-Parkin and YFP-
RAB7A were treated with DMSO (a and b) or valinomycin (c–f) for 3 hr and then subjected to immunoelectron microscopy with anti-GFP antibody.
Panels b and d are the magnified images of boxes in panels a and c, respectively. Bars, 500 nm.
DOI: https://doi.org/10.7554/eLife.31326.006
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Figure 3. RAB7A is required for ATG9A recruitment to damaged mitochondria and encapsulation by autophagic membranes. (A) siRNA-treated HeLa
cells stably expressing mCherry-Parkin were treated with DMSO or valinomycin (Val) for 3 hr. Total cell lysates were analyzed by immunoblotting. (B)
siRNA-treated HeLa cells stably expressing mCherry-Parkin and YFP-LC3B were treated with DMSO or valinomycin for 3 hr. The fixed cells were
subjected to immunostaining. Images are displayed as z-stacks of five confocal slices. The magnified pictures of the cells treated with valinomycin were
Figure 3 continued on next page
Yamano et al. eLife 2018;7:e31326. DOI: https://doi.org/10.7554/eLife.31326 7 of 32
Research article Cell Biology
preferentially bound to Rab GDP-locked form and (2) Rab-GEFs might be a determinant for the cor-
responding Rab membrane targeting (Blu¨mer et al., 2013). 2  HA-tagged RAB7A T22N mutant
(2HA-RAB7A T22N) and mCherry-Parkin stably expressing cells treated with or without valinomycin
were subjected to HA-agarose immunoprecipitation (HA-IP) followed by mass spectrometry analysis.
Several proteins identified by our mass spectrometry are previously known to be involved in Rab
and lysosomal functions (Figure 6A, and Supplementary file 1); ARL8B for lysosome dynamics
(Marwaha et al., 2017; Mrakovic et al., 2012), ATP6V1A, a component of lysosomal ATPase, GDI1
and GDI2 that can solubilize prenylated Rab proteins in the cytosol, MON1A, MON1B and CCZ1,
subunits of the MON1/CCZ1 complex as a RAB7A-GEF (Gerondopoulos et al., 2012;
Nordmann et al., 2010). Although several mitochondrial proteins were identified as RAB7A-interact-
ing proteins (Figure 6A), we further analyzed the MON1/CCZ1 complex. We first confirmed that the
MON1/CCZ1 complex preferentially interacts with the GDP form of RAB7A. Although overex-
pressed MON1/CCZ1 complex remained in the cytosol in the presence of DsRed-RAB7A WT
(Figure 6B), it accumulated on late endosomes/lysosomes when expressing DsRed-RAB7A T22N
(Figure 6B). To test whether the MON1/CCZ1 complex is involved in RAB7A recruitment to dam-
aged mitochondria, we knocked them down in TBC1D15/17 DKO cells because of the efficient
RAB7A mitochondrial translocation (Figure 6C). Although knocking down either MON1A or MON1B
did not inhibit RAB7A recruitment to the mitochondria, the combination of MON1A and MON1B
siRNAs impaired RAB7A recruitment (Figure 6C–E). This is because MON1A and MON1B function
redundantly in the cells we used (Figure 6A). CCZ1 siRNA also inhibited RAB7A recruitment to the
mitochondria (Figure 6C–E), indicating that the MON1/CCZ1 complex is required for mitochondrial
recruitment of RAB7A.
RAB5 is recruited to damaged mitochondria during mitophagy
In the endocytosis pathway, RAB5 functions as the upstream Rab protein, which transfers the signal
to the downstream MON1/CCZ1 complex. Therefore, we examined RAB5 localization during
mitophagy. Under basal conditions, 3  HA-tagged mouse RAB5C (3HA-mRAB5C) mainly localizes
on the early endosomes marked by EEA1 (Figure 7—figure supplement 1A) and does not colocal-
ize with mitochondria (Figure 7A). On the other hand, a part of the 3HA-mRAB5C signals in WT cells
weakly merged with TOMM20 after 3 hr of valinomycin treatment. Furthermore, RAB5C recruitment
to damaged mitochondria was greatly enhanced in TBC1D15/17 DKO cells (Figure 7A). Another
RAB5 variant RAB5B behaved similarly to RAB5C (Figure 7—figure supplement 1B and C).
Figure 3 continued
shown. Bars, 10 mm. (C) The number of autophagosomes containing PDHA1 inside in each cell was counted. Error bars represent mean ±SE of at least
two independent experiments. Statistical differences were determined by student’s t-test. ***p<0.001. (D) The fixed cells as in (A) were subjected to
immunostaining. Images are displayed as z-stacks of five confocal slices. Magnified images are shown for cells treated with valinomycin. Bars, 20 mm. (E)
Quantification of ATG9A recruitment to damaged mitochondria in (D). Overlapped ATG9A signals with mitochondria-localized mCherry-Parkin per total
ATG9A signals were measured. Total ATG9A signal in each cell set to 100%. Error bars represent mean ±SE. Cells from at least two independent
experiments were quantified. Statistical difference was determined by student’s t-test. ***p<0.001. (F) Quantification of ATG9A localization on Golgi
apparatus (see the Materials and methods for the detail). Error bars represent mean ±SE. Cells from at least two independent experiments were
quantified. Statistical difference was determined by student’s t-test ***p<0.001; n.s., not significant.
DOI: https://doi.org/10.7554/eLife.31326.007
The following source data and figure supplements are available for figure 3:
Source data 1. The number of autophagosomes during mitophagy in cells treated with control or RAB7A siRNA.
DOI: https://doi.org/10.7554/eLife.31326.009
Source data 2. This excel file contains quantification of ATG9A recruitment to damaged mitochondria.
DOI: https://doi.org/10.7554/eLife.31326.010
Source data 3. Quantification of ATG9A localization.
DOI: https://doi.org/10.7554/eLife.31326.011
Figure supplement 1. Recruitment of autophagy-related proteins to mitochondria during mitophagy.
DOI: https://doi.org/10.7554/eLife.31326.008
Figure supplement 1—source data 1. source data1 This excel file contains quantification of recruitment/assembly of autophagy-related proteins, GFP-
ULK1, GFP-ATG13, GFP-DFCP1, GFP-WIPI1 and ATG16L1 during mitophagy.
DOI: https://doi.org/10.7554/eLife.31326.012
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Endogenous RAB5, which localizes on the early endosomes under normal growing conditions
(Figure 7B), was also recruited to damaged mitochondria during mitophagy and the recruitment
was accelerated by loss of TBC1D15/17 or loss of FIS1 (Figure 7C). In sharp contrast, RAB17 and
RAB29 stayed in the cytosol and on the Golgi apparatus, respectively, during mitophagy (Figure 7—
figure supplement 1D–F), demonstrating that mitochondrial recruitment is specific for RAB5 and
RAB7A.
RABGEF1 is recruited to damaged mitochondria in a ubiquitin-binding-
dependent manner
We examined the role of the RAB5-GEF, RABGEF1, and found that mitochondrial recruitment of
RAB5C was inhibited by knocking down of RABGEF1 but not by knocking down of the MON1/CCZ1
complex or RAB7A (Figure 7D and E). Interestingly, in addition to the GEF domain, RABGEF1 has
two different UBDs at the N-terminus (Lee et al., 2006; Penengo et al., 2006). Overexpressed GFP-
tagged mouse RABGEF1 (GFP-mRABGEF1) localizes in the cytosol under normal growing conditions
(Figure 8A and B). With Parkin translocation after 3 hr of valinomycin treatment, GFP-mRABGEF1 is
Figure 4. Loss of mitochondrial Rab-GAPs induced excess amounts of ATG9A on damaged mitochondria. (A) HeLa cells stably expressing YFP-LC3B
and mCherry-Parkin were treated with valinomycin for 3 hr followed by immunostaining. Magnified images of boxes (a) and (b) are shown in the right.
Bars, 10 mm. (B) The indicated HCT116 cells stably expressing YFP-LC3B and mCherry-Parkin were treated with valinomycin for 3 hr followed by
immunostaining. Bars, 10 mm. (C) YFP-LC3B and ATG9A signals prepared as in (B) were processed, and overlapped ATG9A signal with YFP-LC3B per
total ATG9A signals in each cell were measured. Total ATG9A signal in each cell set to 100%. Error bars represent mean ±SE. Statistical difference was
determined by student’s t-test. ***p<0.001.
DOI: https://doi.org/10.7554/eLife.31326.013
The following source data and figure supplement are available for figure 4:
Source data 1. Quantification of colocalization of ATG9A and YFP-LC3B signals during mitophagy.
DOI: https://doi.org/10.7554/eLife.31326.015
Figure supplement 1. ATG9A and ATG16L1 recruitment to mitochondria in TBC1D15/17 DKO cells.
DOI: https://doi.org/10.7554/eLife.31326.014
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Figure 5. RAB7A is required for mitophagy. (A) siRNA-treated HeLa cells stably expressing YFP-Parkin were treated with valinomycin (Val) for the
indicated times and total cell lysates were analyzed by immunoblotting. I and II denote unmodified and lipidated LC3B, respectively. (B) Cells in (A)
were subjected to immunostaining. DAPI was used for nuclei staining since anti-mtDNA antibody non-specifically stains nuclei of the cells having no
mtDNA. Magnified pictures were shown for mtDNA degradation in cells treated with valinomycin for 24 hr. Bars, 20 mm. (C) Quantification of YFP-Parkin
translocation to mitochondria after 3 hr of valinomycin treatment. Partial and complete denote that Parkin translocates to some of or all mitochondria,
respectively. Error bars represent mean ±SE and over 100 cells were counted in each of three separate wells. (D - F) Percentages of cells having the
indicated amount of TOMM20 (D), PDHA1 (E) and mtDNA (F) after 24 hr of valinomycin treatment were shown. Error bars represent mean ±SE from
three independent replicates. Over 100 cells were counted in each of three separate wells.
DOI: https://doi.org/10.7554/eLife.31326.016
The following source data is available for figure 5:
Source data 1. This excel file contains quantification of YFP-Parkin recruitment to damaged mitochondria, degradation of TOMM20, and degradation
of PDHA1 upon mitophagy.
DOI: https://doi.org/10.7554/eLife.31326.017
Source data 2. Quantification of mtDNA degradation upon mitophagy.
DOI: https://doi.org/10.7554/eLife.31326.018
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Figure 6. MON1/CCZ1 complex is required for RAB7A recruitment to damaged mitochondria. (A) Lysates of TBC1D15/17 DKO HCT116 cells stably
expressing mCherry-Parkin and 2HA-RAB7A (T22N) were subjected to HA-IP, followed by trypsin digestion and mass spectrometric analysis. High-
confidence candidate interacting protein (HCIPs) partners of RAB7A (T22N) are color-coded: untreated (green outline) and 3 hr of valinomycin (magenta
outline). Line quality as described in figure key indicates criteria used for inclusion. (B) EGFP-MON1B and untagged CCZ1 (or EGFP-CCZ1 and
untagged MON1B) were transiently expressed with DsRed-RAB7A (WT or T22N) in HeLa cells. Bars, 10 mm. (C) siRNA-treated TBC1D15/17 DKO cells
stably expressing mCherry-Parkin and 2HA-RAB7A were treated with valinomycin for 3 hr and subjected to immunostaining. Bars, 10 mm. (D) RAB7A
recruitment to mitochondria in (C) was quantified. Total signals of 2HA-RAB7A in each cell set to 100%. Error bars represent mean ±SE of at least two
independent experiments. Statistical differences were determined by one-way ANOVA with Dunnett’s multiple comparisons test. ***p<0.001; n.s., not
significant. (E) HCT116 cells or those stably expressing GFP-MON1B were treated with the indicated siRNAs. Total cell lysates were analyzed by
immunoblotting. GFP-MON1B was detected by anti-GFP antibody.
DOI: https://doi.org/10.7554/eLife.31326.019
The following source data is available for figure 6:
Source data 1. This excel file contains quantification of 2HA-RAB7A recruitment to mitochondria in TBC1D15/17 DKO cells.
DOI: https://doi.org/10.7554/eLife.31326.020
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Figure 7. RAB5 is recruited to damaged mitochondria during mitophagy. (A) WT or TBC1D15/17 DKO cells stably expressing mCherry-Parkin and 3HA-
mRAB5C were treated with DMSO or valinomycin for 3 hr. The cells were subjected to immunostaining. The magnified pictures were shown in the right.
Bars, 10 mm. (B) HCT116 cells were subjected to immunostaining. Bars, 20 mm. (C) The indicated HCT116 cells stably expressing mCherry-Parkin were
treated with DMSO or valinomycin for 3 hr followed by immunostaining. The magnified pictures were shown in the right. Bars, 10 mm. (D) siRNA-treated
TBC1D15/17 DKO cells stably expressing mCherry-Parkin and 3HA-mRAB5C were treated with valinomycin for 3 hr and subjected to immunostaining.
Bars, 10 mm. (E) Quantification of mRAB5C recruitment to damaged mitochondria in (D). Total signals of 3HA-mRAB5C in each cell set to 100%. Error
Figure 7 continued on next page
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also robustly recruited to the mitochondria (Figure 8A and B). RABGEF1 recruitment to mitochon-
dria requires both Parkin expression and loss of membrane potential (Figure 8—figure supplement
1A) and was observed both in WT and TBC1D15/17 DKO cells with similar efficiencies (Figure 8—
figure supplement 1A). GFP-mRABGEF1 expressed at lower level was also recruited to the mito-
chondria (Figure 8—figure supplement 1B and C). When introducing Y26A/A58D mutations to dis-
rupt ubiquitin-binding ability (described later and [Lee et al., 2006; Penengo et al., 2006]), the
translocation of RABGEF1 was completely blocked (Figure 8A and C), strongly suggesting that RAB-
GEF1 binds to poly-ubiquitin chains that Parkin builds on damaged mitochondria. Consistent with
this, knocking down of the downstream Rab-related factors including MON1, CCZ1, and RAB7A did
not affect the mitochondrial recruitment of RABGEF1 (Figure 8—figure supplement 2).
To investigate biochemical features of RABGEF1 UBD, we purified recombinant mouse RABGEF1
UBD (WT, Y26A, A56D and Y26A/A58D) fused with a GST tag at the N-terminus (GST-mRABGEF1)
from bacterial cells (Figure 8—figure supplement 3A). Recombinant linear tandem (1, 2, 3,
and 4) ubiquitins (Figure 8—figure supplement 3B) were incubated with GST-mRABGEF1. GST-
mRABGEF1 WT efficiently pulled down 2  and higher ubiquitin chains (Figure 8D and E). When sin-
gle mutations, Y26A or A58D, were introduced, the amounts of eluted ubiquitin were slightly
reduced compared to WT (Figure 8D and E). In sharp contrast, the double mutation Y26A/A58D
completely lost the ability to bind ubiquitin (Figure 8D and E). The binding ability to phosphorylated
ubiquitin, which was produced by incubating with recombinant TcPINK1 (Figure 8—figure supple-
ment 3C) was also tested. The overall binding profiles were quite similar to those of non-phosphory-
lated ubiquitin (Figure 8D and E). As Parkin on damaged mitochondria mainly makes K48- and K63-
linked ubiquitin chains (Ordureau et al., 2014), we built K48- and K63-linked ubiquitin chains in vitro
(Figure 8F). RABGEF1 WT, and single Y26A and A58D mutants could bind both K48- and K63-linked
ubiquitin or phosphorylated ubiquitin chains, but Y26A/A58D mutant completely did not
(Figure 8F). To calculate the binding constant between ubiquitin and RABGEF1, isothermal titration
calorimetry (ITC) was used. ITC showed that mouse RABGEF1 UBD interacts with monomeric non-
phosphorylated and phosphorylated ubiquitin with a dissociation constant of 2.2 mM and 5.6 mM,
respectively (Figure 8G, and Figure 8—figure supplement 3D and E). All these biochemical results
strongly suggest that neither ubiquitin-chain linkage nor S65 phosphorylation substantially affect the
binding affinity between ubiquitin and RABGEF1.
RABGEF1 is important for efficient elimination of damaged
mitochondria
The above results suggest that RABGEF1 is involved in mitophagy. To degrade endogenous RAB-
GEF1 rapidly, we utilized auxin-inducible degron technology (Nishimura et al., 2009). The mAID (a
68-aa fragment of the original AID/IAA17) tag was genetically inserted at the C-terminus of RAB-
GEF1 in HCT116 cells stably expressing an F-box component of plant E3 ligase, OsTIR1 (See Materi-
als and methods for the details, (Natsume et al., 2016), yielding the RABGEF1-mAID cell line.
RABGEF1-mAID, but not WT RABGEF1, was degraded within 16 hr of indolacetic acid (IAA) treat-
ment (Figure 9A), a half-life that is much shorter than conventional siRNA methods. To test whether
RABGEF1 is required for mitochondrial elimination via autophagy, WT and RABGEF1-mAID cells sta-
bly expressing YFP-Parkin were treated with IAA and valinomycin for various times. The efficiency of
Parkin translocation (Figure 9B) and MFN2 degradation (Figure 9C) did not change after RABGEF1
degradation. However, TOMM20 and MT-CO2 degradation was slightly inhibited in RABGEF1-mAID
Figure 7 continued
bars represent mean ±SE of at least two independent experiments. Statistical differences were determined by one-way ANOVA with Dunnett’s multiple
comparisons test. ***p<0.001; n.s., not significant.
DOI: https://doi.org/10.7554/eLife.31326.021
The following source data and figure supplement are available for figure 7:
Source data 1. This excel file contains quantification of 3HA-RAB5C recruitment to mitochondria in TBC1D15/17 DKO cells.
DOI: https://doi.org/10.7554/eLife.31326.023
Figure supplement 1. Localization of RAB5B, RAB29, and RAB17 during mitophagy.
DOI: https://doi.org/10.7554/eLife.31326.022
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Figure 8. RABGEF1 is recruited to the damaged mitochondria in a ubiquitin-binding dependent manner. (A) HeLa cells transiently expressing mChery-
Parkin and GFP-mRABGEF1 were treated with DMSO or valinomycin for 3 hr followed by immunostaining. The magnified pictures were shown in the
right. Bars, 10 mm. (B) Total cell lysates of (A) were analyzed by immunoblotting. Anti-GFP antibody was used for the GFP-mRABGEF1 detection. * and
# denote ubiquitinated forms and truncated forms, respectively. (C) Quantification of RABGEF1 recruitment to damaged mitochondria in (A). None,
Figure 8 continued on next page
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cells when compared to WT cells (Figure 9C). We also applied a more quantitative and sensitive
mitophagy assay: Mitochondria-targeted mKeima (mt-mKeima) FACS assay (Lazarou et al., 2015).
When damaged mitochondria are engulfed into lysosomes, a spectral shift of mt-mKeima occurs
owing to the low pH following lysosomal fusion (Katayama et al., 2011). We found a substantial
fluorescent shift by 6 hr of OAQ (oligomycin and antimycin A) treatment in WT cells, which was
impaired in RABGEF1-mAID cells (Figure 9D and E). These results strongly suggest that RABGEF1 is
important for efficient elimination of damaged mitochondria through autophagy.
Mitochondrial localization of TBC1D15 and TBC1D17
TBC1D15 was identified as a FIS1-binding protein (Onoue et al., 2013), and we previously con-
firmed that mitochondrial localization of TBC1D15 and TBC1D17 depends on FIS1 (Yamano et al.,
2014) (). As previously reported, overexpressed TBC1D15 and TBC1D17 localize in cytosol, but FIS1
overexpression direct them to the mitochondria (Figure 10A). To test whether endosomal Rab pro-
teins and their GEFs regulate the mitochondrial localization of TBC1D15 during mitophagy, we
knocked them down and observed endogenous TBC1D15 during mitophagy. In control siRNA-
treated cells, endogenous TBC1D15 was colocalized with TOMM20, and none of the endosomal
Rab knock-down abrogated mitochondrial localization of TBC1D15 (Figure 10B), strongly suggest-
ing that mitochondrial localization of TBC1D15 (and TBC1D17) depends on FIS1, but not endosomal
Rabs and their related factors.
Discussion
Mitochondria, organelles believed to have evolved from proteobacteria, are quite independent from
endomembranes. As mitochondria obtain their constituents (protein, tRNA and lipid) by individual
transport systems, they were thought to have little contact with vesicle transport systems including
Figure 8 continued
partial and complete denote that GFP-mRABGEF1 signals were overlapped with no, some of, and all mitochondria, respectively. (D) Recombinant
ubiquitin (Ub) pre-treated with or without GST-TcPINK1 was subjected to pull-down assay with GST-mRABGEF1. W and E indicate wash and eluted
fractions, respectively. 10%, 10% of input. (E) Percentages of the amount of ubiquitin in the eluted fraction in (D) were shown. The error bars represent
mean ±SE from three independent experiments. (F) K48-linked and K63-linked Ub chains pre-treated with or without GST-TcPINK1 were subjected to
pull-down assay with GST-mRABGEF1. (G) Interactions between GST-mRABGEF1 (WT or Y26A/A58D) and ubiquitin or phosphorylated ubiquitin were
measured by ITC. N, stoichiometry of binding.
DOI: https://doi.org/10.7554/eLife.31326.024
The following source data and figure supplements are available for figure 8:
Source data 1. Quantification of RABGEF1 recruitment to damaged mitochondria during mitophagy.
DOI: https://doi.org/10.7554/eLife.31326.028
Source data 2. Binding affinities of recombinant GST-mRABGEF1 with ubiquitin or phosphorylated ubiquitin.
DOI: https://doi.org/10.7554/eLife.31326.029
Source data 3. Binding affinities of recombinant GST-mRABGEF1 with ubiquitin or phosphorylated ubiquitin.
DOI: https://doi.org/10.7554/eLife.31326.030
Figure supplement 1. RABGEF1 recruitment to mitochondria during mitophagy.
DOI: https://doi.org/10.7554/eLife.31326.025
Figure supplement 1—source data 1. This excel file contains quantification of RABGEF1 (WT and Y26A/A58D mutant) recruitment to mitochondria in
HCT116 (WT and TBC1D15/17 DKO) cells.
DOI: https://doi.org/10.7554/eLife.31326.031
Figure supplement 2. Mitochondrial recruitment of RABGEF1 is not affected by the downstream Rabs and Rab-related factors.
DOI: https://doi.org/10.7554/eLife.31326.026
Figure supplement 2—source data 2. Quantification of RABGEF1 recruitment to mitochondria in HeLa cells treated with the indicated siRNA during
mitophagy.
DOI: https://doi.org/10.7554/eLife.31326.032
Figure supplement 2—source data 3. Quantification of RABGEF1 recruitment to mitochondria in HCT116 cells treated with the indicated siRNA during
mitophagy.
DOI: https://doi.org/10.7554/eLife.31326.033
Figure supplement 3. Preparation of recombinant RABGEF1 and ubiquitin.
DOI: https://doi.org/10.7554/eLife.31326.027
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Rab protein-regulated pathways. However, in this study, we found that core regulators of vesicle
transport system in the endosomal Rab cascade have an ability to associate with mitochondria dur-
ing their engulfment by autophagosomes (Figure 11). In the endocytosis pathway, sequential trans-
port from early to late endosomes requires evolutionally conserved Rab cascade in the correct
order; RABGEF1 (RAB5-GEF), RAB5, MON1/CCZ1 (RAB7-GEF) and then RAB7A.
Taking advantage of mitochondrial RAB7-GAPs (TBC1D15 and TBC1D17) KO cells, we found
RAB5 and RAB7A were associated to damaged mitochondria during Parkin-mediated mitophagy.
Mitochondrial recruitment of RAB5 and RAB7A was impaired by knocking down of RABGEF1, while
knocking down of MON1/CCZ1 complex impaired only RAB7A. We also found that two elements
for membrane tethering, proper GTPase activity and prenylation are required for the mitochondrial
targeting of RAB7A. Therefore, the sequential Rab cascade on damaged mitochondrial membranes
is in the same order as that occurring during endocytosis. Moreover, RABGEF1, the most upstream
GEF for the endosomal Rab cascade, recognizes mitochondrial damage though the UBD (Figure 11).
According to recent accumulating evidence, ubiquitination of damaged mitochondria constitutes a
signal for encapsulation by autophagic membranes (Herhaus and Dikic, 2015). Poly-ubiquitinated
chains conjugated to many different OMM proteins are recognized by UBD-containing proteins. The
most studied ubiquitin-binding proteins are autophagy receptors that also contains LC3-interacting
motif (Birgisdottir et al., 2013) indicating that they recruit LC3-labeled membranes to the damaged
Figure 9. RABGEF1 is important for mitochondrial clearance. (A) WT and RABGEF1-mAID HCT116 cells were treated with or without IAA for 16 hr.
Total cell lysates were analyzed by immunoblotting. (B) Quantification of Parkin recruitment to mitochondria in WT and RABGEF1-mAID HCT116 cells
after 3 hr of valinomycin treatment. Partial and complete denote that YFP-Parkin signals were overlapped with some of and all mitochondria,
respectively. (C) YFP-Parkin stably expressing WT and RABGEF1-mAID HCT116 cells pre-treated with IAA were treated with valinomycin for the
indicated times. Total cell lysates were analyzed by immunoblotting. (D) WT and RABGEF1-mAID HCT116 cells stably expressing YFP-Parkin and mt-
mKeima were treated with IAA for 16 hr followed by DMSO or OAQ for 6 hr and subjected to FACS analysis. Plots are representative of n = 3
experiments. (E) Quantification of mitophagy in (D). Error bars represent mean ±SE of three independent experiments. Statistical differences were
determined by student’s t-test. *p<0.05.
DOI: https://doi.org/10.7554/eLife.31326.034
The following source data is available for figure 9:
Source data 1. Quantification of YFP-Parkin recruitment to mitochondria in RABGEF1-mAID HCT116 and the corresponding WT cells during mitophagy.
DOI: https://doi.org/10.7554/eLife.31326.035
Source data 2. Quantification of mitophagy using mt-mKeima and FACS analysis.
DOI: https://doi.org/10.7554/eLife.31326.036
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mitochondria. In this study, we identified that RABGEF1 is recruited to damaged mitochondria in a
UBD-dependent manner, and found that mitochondrial RABGEF1 is a platform for transfer of the
signal to the downstream Rab cascade. A previous report showed that experimentally inducing RAB-
GEF1 localization to mitochondrial membranes would recruit RAB5 to the mitochondria, in support
of our results (Blu¨mer et al., 2013).
What does RAB7A do on the damaged mitochondria? siRNA-based experiment strongly suggests
that RAB7A directs ATG9A vesicles to damaged mitochondria and/or facilitates the assembly of
ATG9A vesicles near damaged mitochondria during Parkin-mediated mitophagy. Moreover, when
excess amounts of RAB7A are recruited to damaged mitochondria by deletion of mitochondrial Rab
-GAPs, an excess amount of ATG9A vesicles is also recruited along with LC3-labeled autophagic
membranes. Considering the correlation between the amount of RAB7A associated to the damaged
mitochondria and the efficiency of ATG9A recruitment, mitochondria-targeted RAB7A likely regu-
lates ATG9A vesicle trafficking during mitophagy (Figure 11). Since ATG9A is a multispanning mem-
brane protein integrated in small vesicles, it is expected that ATG9A moves along the vesicle
trafficking network. Indeed, ATG9A localizes to different membrane compartments such as TGN,
recycling membrane and plasma membrane, whose trafficking as well as autophagosome formation
under starvation conditions are regulated by several Rab proteins (RAB1 and RAB11) and their regu-
lators (TBC1D5, TBC1D14, and TRAPPIII complex) (Lamb et al., 2016; Longatti et al., 2012;
Popovic and Dikic, 2014). Here, we identified RAB7A as a new mitophagy-specific ATG9A vesicle
regulator. ATG9A might be required not only qualitatively but also quantitatively for expanding
LC3-labeled membrane structures. Given that Rab proteins function in membrane fusion, RAB7A on
Figure 10. Mitochondrial localization of TBC1D15. (A) HA-TBC1D15 (upper) and HA-TBC1D17 (lower) with or without YFP-FIS1 were transiently
expressed in HeLa cells. The cells were subjected to immunostaining. Bars, 20 mm. (B) HeLa cells stably expressing GST-Parkin were treated with the
indicated siRNA. After 3 hr of valinomycin treatment, cells were subjected to immunostaining. Bars, 10 mm.
DOI: https://doi.org/10.7554/eLife.31326.037
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mitochondria may facilitate the expansion of phagophore by assisting fusion of ATG9A vesicles with
the phagophore. During starvation-induced autophagy, ATG9A is hard to detect on the growing
phagophore (Koyama-Honda et al., 2013) probably because they do not need to stay there to
enlarge autophagosomal structures. We, therefore, propose that upon Parkin-mediated mitophagy,
RAB7A regulates coordinated action of making precise autophagosome between LC3-labeled pre-
autophagosome membrane and ATG9A vesicles.
The fact that RAB7A appears on the mitochondrial surface more so in TBC1D15/17 DKO cells
may reflect that mitochondria represent an off target site for RAB7A and that the mitochondrial
RAB7-GAPs dissociate RAB7A so it may target adjacent phagophore membranes. Located at junc-
tions between the growing phagophore and mitochondrial membranes, RAB7A recruits ATG9A-
bound vesicles presumably to foster phagophore expansion. RAB5, on the other hand, appears tar-
geted directly to the OMM by RABGEF1 via binding ubiquitin chains catalyzed there by Parkin. One
scenario is that RAB5 on the mitochondria recruits RAB7A to this site where it is dissociated by
TBC1D15/17, perhaps to target local growing phagophores and augment their growth around mito-
chondria. As OPTN and NDP52 initiate phagophore recruitment to invading bacteria, it is tempting
to suggest that a similar Rab pathway may exist to expand phagophore around pathogens. RAB7A
is also recruited to the growing phagophore during xenophagy (Yamaguchi et al., 2009). Therefore,
phagophore expansion regulated by RAB7A might be a shared molecular hub between mitophagy









Continued on next page
Figure 11. Proposed model of mitophagy regulated by endosomal Rab cycles. (1) Through phosphorylation by PINK1, Parkin and ubiquitin ubiquitinate
damaged mitochondria. (2) RABGEF is recruited to mitochondria and (3) endosomal Rab cycles including RAB5 and MON1/CCZ1 complex direct
RAB7A to the mitochondria. (4) ATG9A vesicles are recruited to the autophagosome formation sites, in a RAB7A-dependent manner, where ATG9A
vesicles and LC3-labeled autophagic membranes are assembled. (5) Mitochondrial Rab-GAPs, TBC1D15 and TBC1D17, dissociate RAB7A from the
mitochondrial membranes to complete the Rab cycles.
DOI: https://doi.org/10.7554/eLife.31326.038
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Other Ni-NTA agarose QIAGEN QIAGEN:
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Software, algorithm Photoshop Adobe SCR_014199
Software, algorithm Volocity PerkinElmer SCR_002668
Software, algorithm ZEN microscope
software
Carl Zeiss SCR_013672
Software, algorithm GraphPad Prism v6.0d GraphPad Software SCR_002798
DNA constructs
Retrovirus plasmids pCHAC/YFP-LC3B-IRES-MCS2, pBMNz/YFP-Parkin, pBMNz/mCherry-Parkin,
pBABE-puro/2HA-RAB7A and pBABE-puro/YFP-RAB7A were described previously (Yamano et al.,
2014). Plasmids for transient expression of HA-TBC1D15, HA-TBC1D17, or YFP-FIS1 were also
described previously (Yamano et al., 2014). Q67L mutation or C-terminal four amino acids deletion
in RAB7A gene was introduced by PCR-based mutagenesis using appropriate primers pair and
subcloned into pBABE-puro vector (Addgene plasmid 1764). 2  HA-tagged RAB7A (T22N) gene
from DsRed-rab7 DN (Addgene plasmid 12662) was subcloned into pBABE-puro vector to generate
pBABE-puro/2HA-RAB7A (T22N). MON1B and CCZ1 genes were amplified by PCR from MGC
Human MON1B cDNA (MHS6278-202832311 from Dharmacon) and MGC Human CCZ1 cDNA
(MHS6278-202808650 from Dharmacon) and subcloned into pEGFP-C1 vector (Clontech, Mountain
View, CA) to make pEGFP-MON1B and pEGFP-CCZ1, respectively. When expressing MON1/CCZ1
complex, EGFP-MON1B and untagged CCZ1 genes (or EGFP-CCZ1 and untagged MON1B genes)
were subcloned into pCHAC-MCS1-IRES-MCS2 (Allele Biotechnology, San Diego, CA). Y26A and
A58D mutations in pEGFP-C1/mouse RABGEF1 plasmid (a kind gift from M. Fukuda) were intro-
duced by PCR-based mutagenesis. EGFP-mouse RABGEF1 (WT and mutants) genes were subcloned
into pBABE-puro vector and pBMN-Z vector (Addgene plasmid 1734). Mouse RAB5B, RAB5C,
RAB17 and RAB29 genes (kind gifts from M. Fukuda) were first inserted into BamHI/NotI sites of
pBSK(-)/3  HA (Yamano, unpublished) to put 3  HA tag sequence at their 5’-regions. 3HA-tagged
mRAB5B, mRAB5C, mRAB17, and mRAB29 genes were then subcloned into pBABE-puro vector.
Plasmids for bacterial expression of tandem linear ubiquitins were constructed as follows. Human
ubiquitin (Ub) gene was amplified by PCR using primer pair, BamHI-Ub-F (5’- GGC Cgg atc cAT
GCA GAT TTT CGT GAA AAC  3’) and Ub-BglII-XhoI-R (5’- CCG Gct cga gcc cag atc tAC CAC
CAC GAA GTC TCA ACA  3’). The amplified DNA fragment was treated with BamHI and XhoI and
inserted into BamHI/XhoI sites of pBluscriptII SK(-) vector to make pBSK/1  Ub. To make
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2  tandem Ub, BamHI/XhoI-treated Ub gene was inserted into BglII/XhoI sites of pBSK/1  Ub.
3  Ub and 4  Ub genes were similarly constructed. The resultant tandem Ub genes were subcl-
oned into BamHI/XhoI sites of pET21a(+) vector (Novagen, Madison, WI) to make pET21a(+)/
1  Ub, pET21a(+)/2  Ub, pET21a(+)/3  Ub, and pET21a(+)/4  Ub. For expression of GST-
tagged mouse RABGEF1, mouse RABGEF1 (1-74aa) coding region was subcloned into pGEX-6P-1
vector (GE Healthcare, Piscataway, NJ).
Antibodies
The following antibodies were used for immunoblotting: rabbit anti-GFP (ab6556;
Abcam, Cambridge, MA), mouse anti-MFN2 (ab56889; Abcam), rabbit anti-TOMM20 (sc-11415;
Santa Cruz Biotechnology, Dallas, TX), rabbit anti-LC3B (L7543; Sigma, St. Louis, MO), mouse anti-
MT-CO2 (ab110258; Abcam), mouse anti-Actin (MAB1501R; Millipore, Bedford, MA), mouse anti-
RAB7 (ab50533; Abcam), rabbit anti- RABGEF1 (NBP1-49938; NOVUS
BIOLOGICALS, Littleron, CO), mouse anti-CCZ1 (sc-514290; Santa Cruz Biotechnology), mouse anti-
ubiquitin (sc-8017; Santa Cruz Biotechnology), and rabbit anti-S65 phosphorylated ubiquitin
(described previously [Koyano et al., 2014]).
The following antibodies were used for immunostaining: rabbit anti-GFP (A-11122; Invitrogen,
Grand Island, NY), mouse anti-GFP (A-11120; Invitrogen), rabbit anti-GFP (ab6556; Abcam), rabbit
anti-TOMM20 (sc-11415; Santa Cruz Biotechnology), mouse anti-TOMM20 (sc-17764 Clone F-10;
Santa Cruz Biotechnology), mouse anti-HA (M180-3; MBL Life science, Japan), mouse anti-HA
(HA.11 Clone 16B12; COVANCE, Berkeley, CA), mouse anti-LAMP2 (sc-18822; Santa Cruz Biotech-
nology), mouse anti-EEA1 (610457; BD Biosciences, San Jose, CA), mouse anti-GM130 (610822; BD
Biosciences), mouse anti-pryruvate dehydrogenase E1-alpha subunit (PDHA1) (ab110334; Abcam),
mouse anti-DNA (CBL186; Millipore), rabbit anti-RAB5 (C8B1; Cell Signaling
Technology, Beverly, MA), rabbit anti-RAB7 (D95F2; Cell Signaling Technology), purified rabbit anti-
TBC1D15 (a kind gift from N. Ishihara), and rabbit anti-ATG9A and anti-ATG16L1 (kind gifts from N.
Mizushima).
RNA interference
siRNA oligos were purchased from QIAGEN (Valencia, CA). The target sequences are as follows:
RABGEF1_#7, AACCGGCAAACCAGCATTGAA; MON1A_#2, AGCCGTCAGTGCCATCCATAA;
MON1B_#2, CTGGGTGACCTCCAAATTCGA; CCZ1_#11, CCCGGATTTAATGAAGATTCT;
RAB7A_#5, CACGTAGGCCTTCAACACAAT. Non-targeting control siRNA were described previ-
ously (Lazarou et al., 2013). siRNAs were transfected into cells using Lipofectamine RNAiMAX (Invi-
trogen) according to the manufacture’s instruction. After 24 hr of transfection, the medium was
changed to fresh medium and the cells were gown for further 24 hr before analysis.
Cell culture and transfection
In this study, we used HeLa cells and HCT116 cells. HeLa cells were used as a model system owing
to their robust expression of endogenous PINK1, and HCT116 cells were chosen because they are
largely diploid and amenable to CRISPR/Cas9 KO experiments. Parkin overexpression is required
because HeLa cells do not express Parkin and while HCT116 cells express Parkin but not unough to
trigger robust mitophagy. HeLa and HEK293T cells were cultured in Dulbecco’s Modified Eagle
Medium (DMEM) (Life Technologies, Carlsbad, CA and Sigma) supplemented with 10% (v/v) fetal
bovine serum, 1 mM sodium pyruvate (Life Technologies), 2 mM glutamine (Life Technologies) or 2
mM GlutaMAX (Life Technologies) and nonessential amino acids (Life Technologies). FIS1-/- and
TBC1D15/17 DKO and the corresponding WT HCT116 cells were cultured in McCoy’s 5A medium
(Life Technologies) supplemented with 10% (v/v) fetal bovine serum, 2 mM glutamine or 2 mM Glu-
taMAX, and nonessential amino acids. Cells were cultured at 37˚C in a 5% CO2 incubator. FIS1-/-
and TBC1D15/17 DKO HCT116 cells were engineered previously (Otera et al., 2010;
Yamano et al., 2014). Stable cell lines were established by recombinant retrovirus infection as fol-
lows. Vector particles were produced in HEK293T cells grown in a six-well plate by cotransfection
with Gag-Pol, VSV-G and the aforementioned retrovirus plasmids. After 12 hr of transfection, the
medium was changed to a fresh medium and the cells were further cultivated for 24 hr. The viral
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supernatants were then infected into HeLa cells or HCT116 cells with 8 mg/ml polybrene (Sigma-
Aldrich). FuGENE6 transfection reagent (Promega, Madison, WI) was used for transient expression.
Valinomycin (Sigma-Aldrich) was used at a final concentration of 10 mM. Oligomycin (Calbiochem)
and antimycin A (Sigma) were used at final concentrations of 10 mM and 4 mM, respectively. When
cells were treated with valinomycin or Oligomycin/Antimycin A more than 6 hr, 10 mM Q-VD-OPH
(SM Biochemicals, Anaheim, CA) was added to block apoptotic cell death. Indole-3-acetic acid (IAA)
(Wako, Japan) was used at a final concentration of 500 mM.
Construction of mAID-knock-in cell lines
HCT116 cell carrying a CMV-OsTIR1 transgene at the safe-harbor AAVS1 locus (HCT116-OsTIR1)
were used as a parental strain (Natsume et al., 2016). 247 bp of 5’ and 247 bp of 3’ homology arms
for Human RABGEF1 exon10 containing BamHI site in the middle (total 500 bp) was synthesized and
subcloned into pUC57-Amp (GENEWIZ, South Plainfield, NJ) to prepare RABGEF1-ex10 donor plas-
mid. DNA fragments of in-frame mAID cassette harboring neomycin (Neo) or hygromycin (Hygro)-
resistant markers were inserted into BamHI site of RABGEF1-ex10 donor plasmid to make RAB-
GEF1-ex10-NeoR donor and RABGEF1-ex10-HygroR donor, respectively. We used PrecisionX Cas9
SmartNuclease System (System Bioscineces, Mountain View, CA) to construct a CRISPR/Cas plasmid.
Two DNA oligonucleosides, RX5-CRISPR-Top-F (5’- tgt atg aga cca cGA TCA TCC TGC ATA AAC
TTG  3’) and RX5-CRISPR-Bottom-R (5’- aaa cCA AGT TTA TGC AGG ATG ATC gtg gtc tca  3’)
were annealed and introduced into EF1-hspCas9-H1-gRNA linearized SmartNuclease vector accord-
ing to the manufacture’s instruction. The resultant Cas9-gRNA plasmid was transfected into
HCT116-OsTIR1 cells with aforementioned RABGEF1-ex10-NeoR donor and RABGEF1-ex10-HygroR
donor plasmids using FuGENE HD (Promega). Cells were grown in McCoy’s 5A media in the pres-
ence of 700 mg/ml G418 (Sigma) and 100 mg/ml Hygromycin B (Invitrogen) until forming colonies.
The single colonies were then isolated and total cell lysates were analyzed by immunoblotting with
anti-RABGEF1 antibody to select cell lines with mAID tagging at the both alleles.
Bacterial strains
To construct YH1851, the serB deletion Escherichia coli strain, the DserB::kan marker was transferred
from JW4351 (Baba et al., 2006) to BL21(DE3) (Invitrogen) by P1 transduction. Successful replace-
ment of the chromosomal serB gene was confirmed by PCR amplification, kanamycin resistance and
amino acid auxotrophy for the mutant strain.
Immunocytochemistry and confocal imaging
Cells grown on two-well coverglass chamber slides or on MatTek were fixed with 4% paraformalde-
hyde in PBS for 25 min at room temperature, permeabilized with 0.15%(v/v) TX-100 in PBS for 15
min, and preincubated with 2%(w/v) BSA or 0.1% gelatin in PBS for 30 min. The fixed cells were incu-
bated with primary antibodies and appropriate secondary antibodies (goat anti-rabbit or anti-mouse
IgG, Alexa Fluor 488, 568 or 647 conjugated from Invitrogen) for immunostaining. The images of the
cells were captured using an inverted confocal microscope (LSM510 Meta, or LSM710, Carl
Zeiss, Germany) with a 63/1.4 NA or 40/1.4 oil differential interference contrast Plan-Apochromat
objective lens. For image analysis, Volocity (PerkinElmer, Waltham, MA), ZEN microscope software
(Carl Zeiss) and/or Photoshop (Adobe, San Jose, CA) software were used. To stain nuclear DNA, the
cells were incubated with 0.3 mg/ml DAPI (Thermo Fisher Scientific, Waltham, MA) in PBS for 5 min.
Volocity software (for Figure 1G, Figure 3E, Figure 3F, and Figure 4C) or ZEN software (for
Figure 6D and Figure 7E ) was used for colocalization analysis. Each single cell was first selected as
a ROI, and appropriate thresholds of green and ref channels (for example, an HA-RAB7A signal for
green channel and a TOMM20 signal for red channels) set in each cell. Overlapped HA-RAB7A signal
with a TOMM20 signal per total HA-RAB7A signal intensity in a selected cell (weighted colocalization
coeffcients) was measured. ATG9A recruitment to damaged mitochondria was measured as a value
of overlapped ATG9A signal with mitochondria-targeted mCherry-Parkin signal. Colocalization of
ATG9A with YFP-LC3B was measured as a value of overlapped ATG9A signal with membrane-tar-
geted YFP-LC3B signal. Volocity software was used for the measurement of ATG9A localization ratio
between Golgi and cytosol. First, immunostained GM130-positive Golgi region was selected by a cir-
cle 8.35 mm in diameter as a ROI, and the signal intensity of immunostained ATG9A overlapped with
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the GM130 signal in the ROI were measured for golgi-localized ATG9A. Cytosolic ATG9A signal
intensities were calculated from the average of three randomly selected cytosolic areas, each of
them is a circle 8.35 mm in diameter. Finally, The ratio between Golgi and cytosol was calculated.
Immunoblotting
Cells grown in six-well plate were washed twice with PBS and solubilized with 2% CHAPS buffer (25
mM HEPES-KOH pH 7.5, 300 mM NaCl, 2% (w/v) CHAPS, protease inhibitor cocktail
(Roche, Indianapolis, IN)) on ice for 30 min and then protein concentrations were determined. Pro-
teins precipitated with TCA were lysed with SDS-PAGE sample buffer supplemented with DTT. The
appropriate amounts of proteins were applied and separated on 4–12% Bis-Tris SDS-PAGE (Invitro-
gen) with MES or MOPS SDS running buffer (Invitrogen). After transfer, PVDF membrane were
blocked and incubated with primary antibodies. Proteins were detected using alkaline phosphatase-
conjugated goat anti-mouse or anti-rabbit IgG as secondary antibodies and a BCIP-NBT solution kit
(Nacalai Tesque, Japan). For detecting phosphorylated ubiquitin, anti-rabbit IgG horseradish peroxi-
dase-linked secondary antibodies (GE Healthcare Life Sciences) and Western Lightning Plus-ECL
(PerkinElmer) were used.
Phos-tag PAGE
For analysis of ubiquitin phosphorylation, Phos-tag (Wako) and MnCl2 were added to polyacrylamide
Tris-glycine gels at the levels recommended by the manufacturer.
Mass spectrometry
TBC1D15/17 DKO HCT116 cells stably expressing mCherry-Parkin and 2HA-RAB7A (T22N) were
treated with DMSO or valinomycin for 3 hr. The harvested cells from four 15 cm dishes (approxi-
mately 80% confluent) were then treated with 5 mM DTBP (dimethyl 3,3’-dithiobispropionimidate,
Pierce, Rockford, IL) for 10 min at room temperature. The crosslinking reaction was quenched by
adding 125 mM glycine. After washing with PBS, the cell pellet was solubilized with MCLB buffer (50
mM Tris pH 7.8, 150 mM NaCl, 0.5% NP40) containing protease inhibitor cocktail (Roche) for 15 min
on ice. Cleared cell lysate were then incubated with equilibrated anti-HA beads (Sigma) overnight at
4˚C while gently inverting. Anti-HA beads were washed with ice-cold MCLB buffer containing prote-
ase inhibitor cocktail once, and with ice-cold PBS buffer three times. The bound proteins were eluted
with 250 mg/ml HA peptide (Sigma) in PBS buffer, and then precipitated with 10% trichloroacetic
acid. Precipitated proteins were resuspended in 50 mM Tris pH 8 with 10% acetonitrile and disulfide
bonds reduced by 5 mM DTT (30 min at 55˚C), alkylated with 15 mM iodoacetamide (room tempera-
ture, 30 min in the dark), and excess iodoacetamide quenched by the addition of 10 mM DTT (room
temperature, 20 min in the dark). Proteins were precipitated using chloroform/methanol precipita-
tion and pellets resuspended in 50 mM Tris pH 8.0 with 10% acetonitrile and digested with 25 ng/ml
trypsin overnight at 37˚C. Peptides were desalted on C18 stagetips, dried, resuspended in 10 ml 5%
acetonitrile, 5% formic acid, and 4 ml (in technical duplicate) loaded onto an 18 cm by 100 mm (inner
diameter) C18 column, eluted by a 50 min 8% to 26% acetonitrile gradient and analyzed on a LTQ
linear ion trap mass spectrometer (ThermoFinnigan, San Jose, CA) by MS/MS using a top-10
method. Spectra were searched against a target-decoy database of human tryptic peptides includ-
ing common contaminants using SEQUEST (carbamidomethylation as static modification, oxidation
of methionine residues as variable modification) followed by a linear discriminant analysis with a 2%
false discovery rate. High-confidence interactors were determined using CompPASS analysis
(Sowa et al., 2009).
Recombinant proteins
Recombinant tandem linear ubiquitins were prepared as follows. Escherichia coli BL21-CodonPlus
(DE3)-RIL competent cells (Agilent Technologies, Santa Clara, CA) transformed with pET21 plasmids
encoding 1x, 2x, 3x, and 4x ubiquitins were grown in LB medium supplemented with 100 mg/ml
ampicillin and 25 mg/ml chloramphenicol at 37˚C. Ubiquitins were expressed at 37˚C for 3 hr by addi-
tion of 1 mM IPTG. The bacterial cell pellets after centrifugation were resuspended in TBS buffer (50
mM Tris-HCl pH7.5, 120 mM NaCl) supplemented with lysozyme, DNAse I, DTT, MgCl2, and prote-
ase inhibitor cocktail and stored at  20˚C until used. The frozen cell suspension were thawed and
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sonicated (Advanced-Digital Sonifer, Branson), and insoluble proteins were removed by centrifuga-
tion. The supernatants were mixed with equilibrated Ni-NTA agarose (QIAGEN) for 30 min at 4˚C.
The agarose was then loaded onto a column and washed with TBS buffer containing 20 mM imidaz-
ole. The bound proteins were eluted with 200 mM imidazole. Imidazole was removed via a PD Midi-
Trap G-25 (GE Healthcare).
Recombinant GST-tagged mouse RABGEF1 (1-74aa) (GST-mRABGEF1) WT and mutants were
prepared as follows. BL21-CodonPlus(DE3)-RIL cells harboring pGEX-6P-1 plasmids were grown in
LB medium supplemented with 100 mg/ml ampicillin and 25 mg/ml chloramphenicol at 37˚C. Expres-
sion of GST-mRABGEF1 was induced by addition of 50 mM ZnCl2 and 100 mM IPTG for 16 hr at
16˚C. The bacterial cell pellets after centrifugation were resuspended in TBS buffer (50 mM Tris-HCl
pH7.5, 120 mM NaCl) supplemented with lysozyme, DNAse I, DTT, MgCl2, and protease inhibitor
cocktail and stored at  20˚C until used. The thawed cell suspension was sonicated, and insoluble
proteins were removed by centrifugation. The supernatants were mixed with equilibrated glutathi-
one-Sepharose 4B (GE Healthcare) for 30 min at 4˚C. The sepharose was then loaded onto a column
and washed with TBS buffer containing 1 mM Tris(2-carboxylethyl)phosphine (TCEP; Sigma). The
bound proteins were eluted with TBS buffer containing 1 mM TECP and 20 mM L-glutathione
reduced (GSH; Sigma). The GSH was removed and the buffer was replaced with TBS buffer supple-
mented with 1 mM TCEP and 10%(w/v) glycerol via a PD MidiTrap G-25. Purification of recombinant
GST-TcPINK1 is described previously (Yamano et al., 2015). In vitro ubiquitin phosphorylation was
performed as follows. Mixture of recombinant 1x, 2x, 3x and 4x ubiquitins (each 7.3 mM) was incu-
bated with 2.8 mM recombinant GST-TcPINK1 in kinase buffer (50 mM Tris-HCl pH7.5, 120 mM
NaCl, 10 mM ATP, 50 mM MgCl2, 1 mM TCEP) for 2 hr at 32˚C.
K48- and K63-polyubiquitin chains
K48-linked polyubiquitin chains were produced using recombinant E2-25K (Pickart and Raasi,
2005). 2.4 mg/ml ubiquitin from bovine erythrocytes (U6253; Sigma) was incubated with recombi-
nant 0.5 mM E1 and 10 mM E2-25K in Buffer (50 mM Tris-HCl pH8.0, 4 mM ATP, 5 mM MgCl2, 1 mM
TCEP) at 37˚C for 1 hr. When producing K48-linked S65-phosphorylated polyubiquitin chains, the
above reaction was done in the presence of 2.85 mM GST-TcPINK1 at 32˚C for 2 hr. K63-linked poly-
ubiquitin chains were produced using recombinant Ubc13 and MMS2 (Sato et al., 2008). 2.4 mg/ml
ubiquitin from bovine erythrocytes (U6253; Sigma) was incubated with recombinant 0.5 mM E1, 5 mM
Ubc13 and 5 mM MMS2 in Buffer (50 mM Tris-HCl pH8.0, 4 mM ATP, 5 mM MgCl2, 1 mM TCEP) at
37˚C for 5 hr. When producing K63-linked S65-phosphorylated polyubiquitin chains, 2.85 mM GST-
TcPINK1 was added to the reaction and further incubated at 32˚C for 2 hr.
In vitro binding assay
Recombinant GST-mRABGEF1 WT and mutants were bound to glutathione sepharose by mixing in
TBS buffer containing 1 mM TCEP and 0.1%(v/v) TX-100 for 20 min at 4˚C. Unbound GST-mRAB-
GEF1 was removed by washing the sepharose three times with TBS buffer containing 1 mM TCEP
and 0.1%(v/v) TX-100. Mixture of unphosphorylated or phosphorylated ubiquitins, or K48- or K63-
linked unphosphorylated or phosphorylated polyubiquitin chains were then added and incubated for
30 min at 4˚C. The resin was washed three times with TBS buffer containing 1 mM TCEP and 0.1%(v/
v) TX-100, and proteins were eluted with SDS-PAGE sample buffer.
Isothermal titration calorimetry
S65 phosphorylated ubiquitin was produced in bacterial cells as follows. To anchor TcPINK1 to the
bacterial inner membrane, a DNA fragment encoding 1-40aa of AtpF transmembrane segment was
inserted into pACYC-Duet-1/TcPINK1. pET21a(+)/1xUb and pACYC-Duet-1/AtpF-TcPINK1 were
introduced into YH1851 cells, and the transformants were grown in LB medium supplemented with
100 mg/ml ampicillin and 25 mg/ml chloramphenicol at 37˚C. Expression of phosphorylated ubiquitin
was induced by addition of 300 mM IPTG at 32˚C for 4 hr. The purification process was essentially
the same as that of unphosphorylated ubiquitin except for addition of PhosSTOP phosphatase inhib-
itor cocktail (Roche) in cell suspension buffer. For ITC measurement, the exact same lot buffer was
used. Recombinant ubiquitin, phosphorylated ubiquitin, GST-mRABGEF1 WT and Y26A/A58D were
applied onto a Superdex 75 10/300 column (GE Healthcare) equilibrated with TBS buffer, and buffer
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exchange was carried out on an AKTA purifier system at a flow rate of 0.4 ml/min. Appropriate pro-
tein fractions were collected and concentrated using Amicon Ultra centrifugal filters (Millipore). The
binding affinity of RABGEF1 to ubiquitin or phosphorylated ubiquitin was measured using a Micro-
Cal iTC200 calorimeter (GE Healthcare), with stirring at 1000 rpm at 25˚C. The titration involved 18
injections of 2 ml of 300 mM ubiquitin or phosphorylated ubiquitin at intervals of 120 s into a sample
cell containing 200 ml of 30 mM GST-mRABGEM7 (WT or Y26/A58D). The titration data were ana-
lyzed using the MicroCal OriginTM 7.0 software to determine the enthalpy (DH), dissociation con-
stant (Kd), and stoichiometry of binding (N). Thermal titration data were fit to a single site binding
model and thermodynamic parameters DH and Kd were obtained by fitting to the model. The error
of each parameter shows the fitting error.
Immunoelectron microscopy
TBC1D15/17 DKO HCT116 cells stably expressing YFP-RAB7A and mCherry-Parkin were treated
with or without valinomycin for 3 hr and then fixed for 30 min with 4% paraformaldehyde and 0.1%
glutaraldehyde in PBS. The fixed cells were washed four times with PBS, followed by permeabiliza-
tion for 40 min with 0.1% Saponin and 5% goat serum in PBS. The cells were incubated for 1 hr with
mouse anti-GFP antibody (A-11120; Invitrogen), followed by 1 hr with nanogold-conjugated anti-
mouse IgG antibody (Nanoprobes, Yaphank, NY) and further processing as described previously
(Tanner et al., 1996). Thin sections (~80 nm) were counter stained with uranyl acetate and lead cit-
rate. The sections were examined with a JEOL 200 CX transmission electron microscope. Images
were collected with a digital CCD camera (AMT XR-100; Danvers, MA).
Mt-mKeima-based mitophagy assay with FACS
YFP-Parkin and mt-mKeima were stably expressed in HCT116-OsTIR1 parental (WT) and RABGEF1-
mAID cells via retrovirus infection as previously reported (Lazarou et al., 2015). Stable cell lines
were then seeded in 6-well plates, treated with IAA for 16 hr, then with OAG for 6 hr before har-
vested for FACS analysis following the procedure as shown in Lazarou et al. (2015).
Statistical analysis
Error bars represent SE as indicated in the figure legends. Data were processed in Excel and statisti-
cal analyses were peformed using Excel or GraphPad Prism v6.0d (GraphPad Software, La Jolla, CA).
Statistical analysis of differences between two groups was performed using a two-tailed, unpaired t
test (Excel) and between more than two groups using a one-way analysis of Dunnett’s multiple com-
parisons test. N.s., not significant, *p<0.05, ***p<0.001.
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. Supplementary file 1. Proteomic analysis of 2HA-RAB7A (T22N)-associated proteins during mitoph-
agy. This files contains all raw and analyzed mass spectrometric data and analysis parameters. Prote-
omic analysis of 2HA-RAB7A (T22N)-associated proteins in TBC1D15/17 DKO HCT116 cells stably
Yamano et al. eLife 2018;7:e31326. DOI: https://doi.org/10.7554/eLife.31326 28 of 32
Research article Cell Biology
expressing mCherry-Parkin after 3 hr of valinomycin treatment using CompPASS. The tab labeled
’Analysis’ contains information regarding cell lines used, experimental conditions, descriptions of all
worksheets including raw data that contain the complete lists of all proteins identified, WDN-scores,
Z-scores, and APSMs, and details of each subsequent analysis performed.
DOI: https://doi.org/10.7554/eLife.31326.039
. Transparent reporting form
DOI: https://doi.org/10.7554/eLife.31326.040
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